Search results for: 'cell and gene therapy cold chain'
- Related search terms
- Cell Counting Market by Product
- therapy devices market size
- gener drug market
- cell ad game therapeutics market
- cell continu market by product
-
22 Jul 2016  |  Global  |  Market Research
RFID in the Global Smart Cold Chain Market
Growth of Cloud Computing and Big Data to Ensure Smart Cold Chain
Scope of the report The research report includes the following segments: Product scope: Active RFID, Passive RFID, RFID sensor tags, RTLS Geographic scope: Global End-user scope: RFID companies, Food Manufacturers, Logistics service providers, Cold Chain companies, Food Retail Companies, Pharmaceutical Companies Revenue analysis and forec...
$4,950.00 -
02 Sep 2025  |  Global  |  Technology Research
Technological Advances in Engineered Cell Therapies, Global, 2025–2029
Emerging Trends and Technologies in Engineered Cell Therapies
Engineered cell therapies have become a revolutionary medical field, surpassing conventional methods such as systemic medications and prominent immunosuppression to provide long-lasting, programmable, and targeted treatments for complicated diseases. Recent technical developments in engineered cell therapies examine how the rapid growth of cell eng...
$4,950.00 -
18 Dec 2025  |  Global  |  Market Research
Growth Opportunities in Cell and Gene Therapeutics Market, Forecast to 2030
Platform Innovation, Regulatory Maturity, and Global Capacity Expansion Are Catalyzing the Next Wave of Growth in Cell and Gene Therapy
The global CGT therapeutics market is transitioning from a niche, high-complexity segment into a mainstream, high-growth therapeutic class. Driven by scientific breakthroughs, accelerated regulatory pathways, and the entry of next-generation platforms—including in vivo CRISPR gene editing, allogeneic “off-the-shelf” cell therapies, and automated sm...
$4,950.00 -
24 Nov 2021  |  Global  |  Technology Research
Technology Developments in Viral Vector Manufacturing for Cell and Gene Therapies
Need for Scalable, Reproducible, and Cost-Effective Manufacturing Processes Driving Growth Opportunities
The Frost & Sullivan research service discusses the cell and gene therapy (CGT) market and highlights some key roadblocks in viral vector manufacturing. While many CGT candidates exist in the pipeline, there is a huge capacity deficit that the industry is collaboratively trying to address. Scalability, costs, reproducibility, and overall process ef...
$4,950.00 -
20 Mar 2026  |  Global  |  Technology Research
Innovations and Growth Opportunities in Cell-based Liver Therapy, Bacteriophage Therapeutics, Cell & Gene Therapy, and Small Molecule Therapeutics
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations transforming respiratory medicine, liver regeneration, metabolic disease management, infectious disease therapeutics, neurological disorders, cardiovascular risk reduction, oncology workflows, and nex...
$950.00 -
06 Mar 2024  |  Global  |  Market Research
Growth Opportunities in the Farm-to-Fork Cold Supply Chain
A Comprehensive Analysis of Key Trends and Technologies
The farm-to-fork (F2F) industry encompasses every stage that food passes through before it ends up on the consumer s tables. These stages include agricultural production, intermediate production, and retail trade and services. This study focuses on the cold supply chain of the F2F ecosystem, which specifically involves refrigerated storage and dist...
$4,950.00 -
20 Feb 2026  |  Global  |  Technology Research
Innovations and Growth Opportunities in Cell & Gene Therapy, Targeted Protein Degradation, Bacteriophage Therapeutics, and Advanced Drug Delivery
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides strategic insights into frontier innovations redefining therapeutic development, precision diagnostics, and immune modulating interventions. It showcases breakthroughs across engineered phage therapeutics, intracellular peptide platforms, advanced gene ...
$950.00 -
21 Aug 2026  |  Global  |  Technology Research
Innovations and Growth Opportunities in AI-Driven Biomanufacturing, Advanced Cell and Gene Therapies, and Precision Immunotherapy
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping biomanufacturing, cell and gene therapy, precision immunotherapy, anti-infectives, and neurotherapeutics across oncology, infectious disease, nephrology, and neurodegenerative disease. It hi...
$950.00 -
19 Jan 2023  |  Global  |  Technology Research
Advances in Gene Editing Technologies in Healthcare
Next-generation genome editing tools and improved delivery are bolstering gene editing therapeutics and diagnostics.
Advancements in gene editing technology are boosting its adoption in various fields, including healthcare, diagnostics, agriculture, and industrial biotechnology. CRISPR, ZFNs, and TALENs are examples of technologies that have revolutionized the gene editing field. Moreover, with constant research efforts, new technologies such as base editing, pri...
$4,950.00 -
07 Jul 2020  |  Global  |  Technology Research
Competitive Landscape Analysis of Recent Cell and Gene Therapy Innovations
Emerging Chimeric Antigen Receptor (CAR) T-cell Therapy Platforms
This research identifies some the key developments across CAR-T cell therapies and provides insights across technological, IP, and investment landscapes. The study also provides an analysis of the competitive landscape while highlighting the key growth opportunities within the CAR-T cell therapy platform.
$4,950.00